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Abstract - Following the introduction of measles immunization in Serbia in 1971, measles outbreaks were recorded every 
3 to 5 years until 1997. The outbreak in 1997 with 4000 cases was the last large outbreak in Serbia. In 2007, an outbreak 
with 191 laboratory confirmed or epidemiologically linked cases was reported in Vojvodina. In 2008 and 2009, only 3 cases 
were confirmed. From 2007-2009, measles infections were most frequently detected in the Roma population but also in 
non-immunized or partially immunized persons from the general population.
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INTRODUCTION
The measles virus, a member of the Paramyxoviruses 
family, causes a common, acute infectious disease 
which is characterized by fever, cough, conjunctivitis 
and a generalized, maculopapular rash (Griffin, 2001; 
Rima and Duprex, 2006). Despite the availability of 
effective live vaccines for more than 40 years, measles 
is still responsible for 4% of deaths in children young-
er than 5 years of age worldwide (Bryce et al., 2005).
In Serbia, measles immunization with a mono-
valent vaccine was started in 1971. The bivalent 
measles/mumps immunization program was in-
troduced in 1981. Since 1994, a two-dose schedule 
with trivalent MMR vaccine is used. Additionally, 
a supplementary immunization program of Roma 
population groups was organized from 2002-2004 by 
the Institute of Public Health (IPH) of Serbia and a 
network of 23 IPH and health centers and with the 
financial support of UNICEF.
Measles, rubella and CRS have been notifiable 
diseases in Serbia for decades. Cases are classified ac-
cording to the WHO case definition. The National 
Commission for the Protection of the Population 
from Communicable Diseases adopted an action 
plan for the elimination of measles and prevention 
of CRS in the Republic of Serbia by the end of 2015 
(WHO, 2010a and b). The present manuscript de-
scribes the measles epidemiology in Serbia between 
2007 and 2009.
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MATERIALS AND METHODS
Measles and rubella surveillance in Serbia is organ-
ized by the Institute of Public Health of Serbia and 
Institutes of Public Health throughout the country 
(epidemiological surveillance) and the WHO Mea-
sles/Rubella National Reference Laboratory (M/R 
NRL) at the Institute of Virology, Vaccines and Sera 
“TORLAK” Belgrade (laboratory surveillance). 
Together, they investigate each suspected case and 
outbreaks. The aim is early detection of disease, esti-
mation of the extent of an outbreak, and to establish 
the possible source of infection and transmission 
route. Laboratory confirmation in the M/R NRL is 
done by detection of specific IgM and IgG antibod-
ies using Enzygnost® kits (Siemens Healthcare Di-
agnostics Products GmbH, Marburg/Germany) in 
blood samples, and/or virus detection using nose 
or  throat swabs (Real-time PCR in house test with 
primers and probes from the Statens Institute, Den-
mark, unpublished data) and/or isolation of virus in 
Vero/hSLAM cells. All measles virus positive swabs 
are sent to the WHO European Regional Reference 
Laboratory in Luxembourg (RRL) for confirmation 
and sequence analysis. In this paper, we analyze the 
epidemiological and virological surveillance data 
of measles infection in Serbia in the period 2007-
2009.
RESULTS
Following the introduction of measles immunization 
in Serbia in 1971, measles outbreaks were recorded 
every 3 to 5 years (Fig. 1). The incidence rate was 
90-350 cases per 100,000 between 1971 and 1985 
and 90-150 cases per 100,000 in the period 1986 to 
1993. The outbreak in 1997 with 4000 cases was the 
last big outbreak in Serbia (Fig. 1), and an incidence 
rate of 43/100,000 and 7 fatal outcomes. During the 
following nine years, decreasing case numbers were 
observed and an ever-low incidence of 0.02 cases per 
100,000 was reached in 2005 and 2006. 
In 2007, however, an outbreak with 191 labora-
tory confirmed or epidemiologically linked cases 
occurred in Vojvodina. The index case came from 
Bosnia and Herzegovina to attend a funeral. The 
index case and the majority of registered cases be-
longed to the Roma population. Out of 191 labora-
tory confirmed or epidemiologically linked cases, 
45% were women. The most affected age groups were 
the 20-29 and 10-14 year olds (25.8% and 19.4%, 
respectively), followed by the 5-9 and 15-19 year 
olds (13.9% and 12.4%, respectively). In the popula-
tion older than 30 years, 11.4% were affected, while 
in children from 1-4 the infection was detected in 
10.4%. 
The youngest patient was 8 days old and the 
oldest was 43 years. The large majority of the cases 
(166/191, 87%) were unvaccinated. A total of 47% of 
the patients were hospitalized and 12.9% had com-
plications such as pneumonia.
Mop-up and urgent immunization campaigns 
were conducted in all municipalities in the affected 
high-risk Roma group. To prevent further spread 
and to wipe out the epidemic, the isolation of measles 
cases and vaccination of unvaccinated contacts were 
carried out in schools, hospitals, families, kindergar-
tens, etc. according to the national regulations.
Sequence analysis confirmed the measles virus 
genotype D4, with the main outbreak strain being 
identical to the Romania variant. The same variant 
circulated in 2007 in Bosnia and Herzegovina (Fig. 
2). Molecular analysis of later cases showed that this 
variant stopped circulating in Serbia after the out-
break.
In 2008, only two measles cases were confirmed 
out of 16 suspected and laboratory investigated cases. 
The first case was a man who had travelled to Thai-
land while the second patient was epidemiologically 
linked to him. Sequence analysis identified genotype 
D9 and identical sequences were found in the same 
year in Thailand, supporting the epidemiological link 
to this country (Fig. 2).
In 2009, a single case of measles was confirmed in 
a person who came from Germany. Molecular analy-
sis detected genotype D4, Enfield variant (Fig. 2).
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DISCUSSION
In the pre-vaccination period, measles was a dis-
ease of childhood in Serbia. Recently mostly non-
immunized adults in specific subpopulations, such 
as international travelers, healthcare workers and 
closed communities were affected. The analysis of 
epidemiological and virological surveillance data 
of measles infection in Serbia in the period 2007-
2009 shows that all index cases were imported. In 
2007, the infection spread rapidly in the very mobile 
Roma population, causing an outbreak. Most cases 
occurred in the Roma population but also in non-
immunized or partially immunized persons from the 
general population. Out of 191 laboratory confirmed 
cases, 47 % were hospitalized. The majority of them 
were from the Roma population, who were hospital-
ized due to malnutrition and poor housing condi-
tions. In recent years, several outbreaks of measles in 
Europe were started by traveler communities or they 
were the most affected population group (e.g. Mari-
nova et al., 2009; Orlikova et al., 2010; Pervanidou et 
al., 2010). Pockets of susceptible persons are present 
throughout Europe and they may sustain transmis-
sion and spread the virus across borders (Steffens et 
al., 2010).    
Due to the conflicts in the 1990s in the ex-Yugo-
slav countries, it has been difficult to perform contin-
uous monitoring of the migration of Roma refugees 
and of their immunization status. During a supple-
mentary immunization program of Roma popula-
tion groups in 17 districts between 2002 and 2004, 
36,611 Roma children aged 0-14 years were regis-
tered and included in the Serbia healthcare system. 
The data showed that only 36.3% of these children 
were fully immunized against measles before the 
campaign. The supplementary vaccination program 
was initially planned to cover 23,339 Roma children. 

















Fig. 1. Measles cases and immunization coverage in Serbia 1953-2009
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Fig. 2. Phylogenetic tree based on 450 nucleotides of the measles virus N gene and the Neighbor-Joining and 
Kimura 2-parameter methods of MEGA 4.0 (Tamura et al., 2007). Only bootstrap values (n=1000) above 70 
are shown. Sequences from Serbia are marked with dots (year 2007), a triangle (2008) or a diamond (2009). 
Numbers in brackets behind the sequence names indicate the number of additional identical sequences from 
the same location and year.
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MMR as some refused immunization and others had 
changed their place of residence.
CONCLUSION
To achieve measles elimination in Serbia by 2015, it 
is necessary to maintain vaccination coverage above 
95% for both doses at the national and district lev-
els. It is important to identify susceptible candidates 
among the Roma and the general population and to 
offer supplementary immunization opportunities to 
all non-immune people. Along with this, it is nec-
essary to perform continuous surveillance of the 
disease, including case investigation and laboratory 
confirmation of clinical cases. 
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